These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22311530)

  • 41. Cognitive impairment in individuals currently using methamphetamine.
    Simon SL; Domier C; Carnell J; Brethen P; Rawson R; Ling W
    Am J Addict; 2000; 9(3):222-31. PubMed ID: 11000918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurocognitive effects of methamphetamine: a critical review and meta-analysis.
    Scott JC; Woods SP; Matt GE; Meyer RA; Heaton RK; Atkinson JH; Grant I
    Neuropsychol Rev; 2007 Sep; 17(3):275-97. PubMed ID: 17694436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CYP2D6 genotype may moderate measures of brain structure in methamphetamine users.
    Dean AC; Nurmi EL; Morales AM; Cho AK; Seaman LC; London ED
    Addict Biol; 2021 May; 26(3):e12950. PubMed ID: 32767519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective attention and the three-process memory model for the interpretation of verbal free recall in amyotrophic lateral sclerosis.
    Christidi F; Zalonis I; Smyrnis N; Evdokimidis I
    J Int Neuropsychol Soc; 2012 Sep; 18(5):809-18. PubMed ID: 22676844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Functioning of memory in subjects with autism].
    Gras-Vincendon A; Bursztejn C; Danion JM
    Encephale; 2008 Dec; 34(6):550-6. PubMed ID: 19081450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of an acute d-amphetamine administration on context information memory in healthy volunteers: evidence from a source memory task.
    Zeeuws I; Deroost N; Soetens E
    Hum Psychopharmacol; 2010; 25(4):326-34. PubMed ID: 20521323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Denial in methamphetamine users: Associations with cognition and functional connectivity in brain.
    Dean AC; Kohno M; Morales AM; Ghahremani DG; London ED
    Drug Alcohol Depend; 2015 Jun; 151():84-91. PubMed ID: 25840750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between methamphetamine use and increased dental disease.
    Shetty V; Mooney LJ; Zigler CM; Belin TR; Murphy D; Rawson R
    J Am Dent Assoc; 2010 Mar; 141(3):307-18. PubMed ID: 20194387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine Enhances Item Novelty Detection via Hippocampal and Associative Recall via Left Lateral Prefrontal Cortex Mechanisms.
    Clos M; Bunzeck N; Sommer T
    J Neurosci; 2019 Oct; 39(40):7920-7933. PubMed ID: 31405927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reaction time variability and related brain activity in methamphetamine psychosis.
    Fassbender C; Lesh TA; Ursu S; Salo R
    Biol Psychiatry; 2015 Mar; 77(5):465-74. PubMed ID: 25444164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy.
    Doyle KL; Woods SP; McDonald CR; Leyden KM; Holden HM; E Morgan E; Gilbert PE; Corey-Bloom J
    Appl Neuropsychol Adult; 2019; 26(1):17-27. PubMed ID: 28850256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurocognitive decision-making processes of casual methamphetamine users.
    Droutman V; Xue F; Barkley-Levenson E; Lam HY; Bechara A; Smith B; Lu ZL; Xue G; Miller LC; Read SJ
    Neuroimage Clin; 2019; 21():101643. PubMed ID: 30612937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ; Acheson LS; Lintzeris N; Ezard N
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Executive function in methamphetamine users with and without psychosis.
    Koopowitz SM; Cotton SM; Uhlmann A; Thomas KGF; Stein DJ
    Psychiatry Res; 2022 Nov; 317():114820. PubMed ID: 36075151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive deficits in methamphetamine addiction: Independent contributions of dependence and intelligence.
    Fitzpatrick RE; Rubenis AJ; Lubman DI; Verdejo-Garcia A
    Drug Alcohol Depend; 2020 Apr; 209():107891. PubMed ID: 32061948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of methamphetamine exposure and cross-fostering on cognitive function in adult male rats.
    Hrubá L; Schutová B; Pometlová M; Rokyta R; Slamberová R
    Behav Brain Res; 2010 Mar; 208(1):63-71. PubMed ID: 19900489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired memory and reduced sensitivity to the circadian period lengthening effects of methamphetamine in mice selected for high methamphetamine consumption.
    Olsen RH; Allen CN; Derkach VA; Phillips TJ; Belknap JK; Raber J
    Behav Brain Res; 2013 Nov; 256():197-204. PubMed ID: 23954232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.